Navigating Cell Therapy Supply Chain Challenges

Report Overview

Various factors are contributing to the storage and distribution of clinical trial materials becoming more complex. Ironing out the complexities of clinical logistics can help bring a drug to market faster. The clinical supply process brings on a whole new complexity when cell therapy products are introduced. This points towards a need for highly knowledgeable service providers, and for drug sponsors looking to shepherd cell therapy products through the clinical trial process, ISR wanted to delve deeper into the current best practices and lessons learned when it comes to the clinical supply process for cell therapy products.

ISR’s Navigating Cell Therapy Supply Chain Challenges report will bring you and your company up to speed on how people who have deep experience in clinical logistics for cell therapy products explain how their processes work and what they have learned over time.  
 

What you will learn:
 

Backed by more than 50 verbatim responses from 13 qualitative in-depth interviews, hear directly from people experienced in cell therapy clinical supply chain logistics.
 

Drug Developers:

• Learn from your peers about their experiences with the clinical supply chain when cell therapies are involved
• Included are specific risk mitigation strategies
• There are specific recommendations and “best practices” highlighted throughout the report

Service Providers:

• Learn first-hand the issues sponsors are having with cell therapy clinical supply chain trials and develop marketing messages to address these challenges
• Hear from sponsors the novel approaches they have taken to ensure samples are delivered on time and meet protocol standards

Major Topics:

• Risk Mitigation Strategies and Solutions
• Overview of Cell Therapy and the Supply Chain: Autologous and Allogeneic Supply Chain Process Map
• Cell Therapy Clinical Development Challenges: CMC Role, Patient Logistics
• Cell Therapy Supply Chain & Logistics Challenges: International, Chain Of Custody, Unexpected, Recommended Improvements
• Cell Therapy Supply Chain Outsourcing Dynamics: Vendors, Services Being Outsourced, Capacity, Provider Management